Homeyahoo-finance2
Ascendis Pharma A/S
Indicative price
$253.68
Nov 4, 2026
1
Funds holding
$93.4M
Reported value
350,110
Reported shares
Company profile
Stage
Country
Mark dateNov 4, 2026
Price history
Price per share in USD
Nov 4, 2026O $252.50H $254.01L $248.34C $253.68
Current funds holding Ascendis Pharma A/S
| Fund | Manager | As of | Shares | Fair value | % of fund | AUM |
|---|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF TCAF | T. Rowe Price | Jun 30, 2026 | 350,110 | $93,381,339 | 1.3% | $7.4B |
Published ownership history
Historical positions are grouped by fund and accepted SEC portfolio snapshot.
| Fund | As of | Filing | Shares | Fair value | % of fund |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2026 | NPORT-P | 350,110 | $93,381,339 | 1.3% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2026 | NPORT-P | 333,325 | $76,241,427 | 1.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Sep 30, 2025 | NPORT-P | 50,660 | $10,071,715 | 0.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2025 | NPORT-P | 66,931 | $11,552,291 | 0.2% |
| T. Rowe Price Capital Appreciation Equity ETF | Mar 31, 2025 | NPORT-P | 71,056 | $11,074,788 | 0.3% |
| T. Rowe Price Capital Appreciation Equity ETF | Dec 31, 2024 | NPORT-P | 25,030 | $3,445,880 | 0.1% |